Literature DB >> 748005

Selective blockade of estrogen-induced uterine responses by the antiestrogen nafoxidine.

R M Gardner, J L Kirkland, G M Stancel.   

Abstract

The response of the immature rat uterus to the antiestrogen, nafoxidine (Upjohn U-11, 100A), is maximum at a dose of 5 micrograms. This dose of nafoxidine sustains the uterine response for at least 72 h. After treatment with 5 micrograms nafoxidine for 24 h, uterine cytosol contains approximately one half the total number of estrogen receptors originally present in uteri of untreated animals, and uterine nuclei also contain approximately one half the receptors originally present in unstimulated tissue. The total amount of uterine estrogen receptor, however, is not altered 24 h after treatment with nafoxidine relative to saline-treated controls, while estradiol treatment doubles the total amount of receptor relative to controls. Pretreatment with 5 micrograms nafoxidine for 24 h does not block the uterine response occurring 4 h after the subsequent administration of estradiol, but does block the uterine response occurring 24 h after the subsequent administration of estradiol. These results suggest that uterine nuclei contain different acceptor sites for regulating short term and long term uterine responses to estrogen.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 748005     DOI: 10.1210/endo-103-5-1583

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  2 in total

1.  Effect of progesterone pretreatment on the uptake of estradiol-17 beta by the uterine epithelium of the rat.

Authors:  M A Vass; B Green
Journal:  Cell Tissue Res       Date:  1979-10-02       Impact factor: 5.249

Review 2.  Toxicity of endogenous and environmental estrogens: what is the role of elemental interactions?

Authors:  G M Stancel; H L Boettger-Tong; C Chiappetta; S M Hyder; J L Kirkland; L Murthy; D S Loose-Mitchell
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.